60 DEGREES PHARMACEUTICALS, INC.

60 Degrees Pharmaceuticals, Inc. specializes in the commercial-scale manufacturing, packaging, and validation of pharmaceutical preparations, with a demonstrated focus on complex antimalarial therapeutics such as tafenoquine (ARAKODA). The company possesses deep technical expertise in GMP-compliant production workflows, sterile and non-sterile packaging validation, and end-to-end pharmaceutical supply chain support for government-critical medications. Their capability extends to brand-name drug commercialization, including regulatory-aligned labeling, batch documentation, and quality assurance systems tailored to defense and veteran health requirements. What sets them apart is their precision in executing high-integrity pharmaceutical operations under stringent federal oversight, ensuring product stability, traceability, and compliance with FDA and DoD standards. The contractor has delivered critical pharmaceutical services to the Department of Defense and the Department of Veterans Affairs, primarily supporting the procurement and distribution of specialized therapeutics for military personnel and veteran populations. Their work for DoD centers on the commercial-scale packaging and validation of branded antimalarial agents, while their VA engagement involves sustained supply chain support under Federal Supply Schedule contracts for hematological and pharmaceutical products. These relationships reflect a pattern of trusted, repeat engagement for mission-critical drug logistics and readiness support. Operating under NAICS 325412, the company is positioned within the pharmaceutical preparation manufacturing sector, focusing on finished dosage forms rather than active pharmaceutical ingredient synthesis. Their vertical specialization lies in niche, high-stakes therapeutics used in expeditionary and chronic care settings, particularly those requiring stringent cold-chain or stability controls. As a small business structured as a 2L entity based in Washington, D.C., 60 Degrees Pharmaceuticals operates without federal certifications but maintains a strategic presence in the federal pharmaceutical supply market, leveraging proximity to key policy and procurement hubs to support national health security initiatives.